Oncology 3.0: Towards Personalized Cancer Treatment Course organized within the CTO program of the Utrecht Graduate School of Life Sciences Location lectures: Stratenum 2.112 26-28 November 2014 November 26: Genomics/Genetics 09:30 The future of Medical Oncology: what do we need? Prof. dr. Emile Voest, Medical Director of the Netherlands Cancer Institute 10:30 Coffee break 10:45 NGS technology: Platforms and assays to detect mutations, structural variations and copy number variations Marco Koudijs, PhD, Clinical laboratory geneticist i.t., UMC Utrecht 11:45 Whole genome sequencing in diagnostics Jan Molenaar MD PhD, Postdoc Pediatric Oncology, AMC Amsterdam (onder voorbehoud) 12:45 Lunch break 13:30 Ethical issues: unexpected findings and informed consent Annelien Bredenoord PhD, Julius Center Utrecht 14:30 Practial session (same cases as last year) : Ies Nijman PhD Annelies Smouters?, UMC Utrecht - Cases - Databases 16:30 End November 27: Proteomics and data-integration 09:00 Transcriptomics Lodewyk Wessels, NKI Amsterdam 10:00 Proteomics 2 Connie Jimenez, VU MC Amsterdam 11:00 Coffe break 11:15 TRAIT Gerrit Meijer, VU MC Amsterdam 12:15 Lunch break 13:15 Practical session: TransMart/TRAiT Remond Fijneman VU MC Amsterdam 14:15 R2 workshop Jan Koster, AMC 16:30 End November 28: Drug screens 09:00 Crystallography and drug development Michael Hadders, Postdoc Lens Group UMCU 10:00 Do’s and don’ts in Biotech development Roel Raatgever, managing director UtrechtINC 11:00 Coffee break 11:15 Compound screening (Company) Ruben Postel PhD, Senior Scientist at Somantix, Utrecht 12:15 Lunch Break 13:15 Discussion panel Pharma/Insurance company/Doctor/Researcher/Ethicist Edwin Cuppen, Terry Vrijenhoed (mediator), ……… 15:30 End of course